跳转至内容
Merck
  • Derivation and high engraftment of patient-specific cardiomyocyte sheet using induced pluripotent stem cells generated from adult cardiac fibroblast.

Derivation and high engraftment of patient-specific cardiomyocyte sheet using induced pluripotent stem cells generated from adult cardiac fibroblast.

Circulation. Heart failure (2014-11-26)
Liying Zhang, Jing Guo, Pengyuan Zhang, Qiang Xiong, Steven C Wu, Lily Xia, Samit Sunny Roy, Jakub Tolar, Timothy D O'Connell, Michael Kyba, Kenneth Liao, Jianyi Zhang
摘要

Induced pluripotent stem cells (iPSCs) can be differentiated into potentially unlimited lineages of cell types for use in autologous cell therapy. However, the efficiency of the differentiation procedure and subsequent function of the iPSC-derived cells may be influenced by epigenetic factors that the iPSCs retain from their tissues of origin; thus, iPSC-derived cells may be more effective for treatment of myocardial injury if the iPSCs were engineered from cardiac-lineage cells, rather than dermal fibroblasts. We show that human cardiac iPSCs (hciPSCs) can be generated from cardiac fibroblasts and subsequently differentiated into exceptionally pure (>92%) sheets of cardiomyocytes (CMs). The hciPSCs passed through all the normal stages of differentiation before assuming a CM identity. When using the fibrin gel-enhanced delivery of hciPSC-CM sheets at the site of injury in infarcted mouse hearts, the engraftment rate was 31.91%±5.75% at Day 28 post transplantation. The hciPSC-CM in the sheet also appeared to develop a more mature, structurally aligned phenotype 28 days after transplantation and was associated with significant improvements in cardiac function, vascularity, and reduction in apoptosis. These data strongly support the potential of hciPSC-CM sheet transplantation for the treatment of heart with acute myocardial infarction.

材料
货号
品牌
产品描述

Sigma-Aldrich
单克隆 抗-α-肌动蛋白(肌小节) 小鼠抗, clone EA-53, ascites fluid
Sigma-Aldrich
抗核抗体,克隆 235-1,Cy3 结合物, clone 235-1, from mouse, CY3 conjugate